Blood test may replace biopsies for bile duct cancer patients
NCT ID NCT07142226
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study is testing whether a blood test that looks for tumor DNA (ctDNA) can be as good as a tissue biopsy for finding genetic changes in advanced bile duct cancer. Researchers will enroll 200 adults with advanced biliary tract cancer across multiple hospitals in Korea. The goal is to see if this simpler, faster test can help doctors choose the right targeted therapy without needing a tissue sample.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BILIARY TRACT CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Bundang CHA Medical Center
RECRUITINGSeongnam-si, Gyeonggi-do, 13496, South Korea
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a smart drug home in on Hard-to-Treat cancers?
- Can a new immunotherapy combo shrink Hard-to-Treat tumors?
- Can two targeted drugs boost chemo against a rare Bile-Duct cancer?
- New drug cocktail aims to outperform standard immunotherapy in bile duct cancer
- Liver cancer registry aims to uncover new biomarkers from thousands of patients
- Triple-Drug cocktail targets Hard-to-Treat biliary cancers